KeyCorp started coverage on shares of ICU Medical, Inc. (NASDAQ:ICUI) in a research note published on Tuesday, October 17th, MarketBeat.com reports. The firm issued a sector weight rating on the medical instruments supplier’s stock.
Other equities analysts have also issued research reports about the stock. Zacks Investment Research upgraded shares of ICU Medical from a hold rating to a buy rating and set a $193.00 price target for the company in a research report on Thursday, July 20th. Gabelli reiterated a buy rating on shares of ICU Medical in a research report on Friday, August 11th. BidaskClub upgraded shares of ICU Medical from a sell rating to a hold rating in a research report on Friday, August 18th. Finally, Sidoti lowered shares of ICU Medical from a buy rating to a neutral rating in a research report on Tuesday, June 20th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company. The company presently has a consensus rating of Hold and a consensus target price of $193.00.
ICU Medical (NASDAQ:ICUI) traded up $2.55 on Tuesday, reaching $193.45. 59,415 shares of the company’s stock traded hands, compared to its average volume of 102,784. The firm has a market capitalization of $3,813.72, a P/E ratio of 52.59 and a beta of 0.33. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.66 and a current ratio of 4.78. ICU Medical has a 1 year low of $127.00 and a 1 year high of $195.20.
ICU Medical (NASDAQ:ICUI) last announced its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.06). The firm had revenue of $331.51 million during the quarter, compared to analysts’ expectations of $318.30 million. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business’s revenue for the quarter was up 242.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.15 EPS. analysts forecast that ICU Medical will post -3.52 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “KeyCorp Begins Coverage on ICU Medical, Inc. (ICUI)” was originally reported by BBNS and is the property of of BBNS. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://baseballnewssource.com/markets/icu-medical-inc-icui-now-covered-by-keycorp/1721851.html.
In other news, VP Virginia Ruth Sanzone sold 1,784 shares of the firm’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $174.47, for a total value of $311,254.48. Following the transaction, the vice president now owns 102 shares in the company, valued at $17,795.94. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert S. Swinney sold 3,400 shares of the firm’s stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $173.98, for a total transaction of $591,532.00. Following the completion of the transaction, the director now owns 20,893 shares in the company, valued at approximately $3,634,964.14. The disclosure for this sale can be found here. Insiders sold 120,247 shares of company stock worth $22,708,888 over the last ninety days. 13.60% of the stock is currently owned by insiders.
Large investors have recently added to or reduced their stakes in the stock. Castleark Management LLC bought a new stake in ICU Medical in the second quarter valued at $283,000. Personal Capital Advisors Corp bought a new stake in ICU Medical in the second quarter valued at $1,494,000. Citigroup Inc. boosted its holdings in ICU Medical by 104.3% in the second quarter. Citigroup Inc. now owns 17,190 shares of the medical instruments supplier’s stock valued at $2,965,000 after acquiring an additional 8,775 shares in the last quarter. Fiera Capital Corp bought a new stake in ICU Medical in the second quarter valued at $36,962,000. Finally, Royce & Associates LP boosted its holdings in ICU Medical by 26.7% in the second quarter. Royce & Associates LP now owns 47,400 shares of the medical instruments supplier’s stock valued at $8,177,000 after acquiring an additional 10,000 shares in the last quarter. Institutional investors and hedge funds own 78.16% of the company’s stock.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with our FREE daily email newsletter.